BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28614376)

  • 41. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.
    Grohskopf LA; Blanton LH; Ferdinands JM; Chung JR; Broder KR; Talbot HK; Morgan RL; Fry AM
    MMWR Recomm Rep; 2022 Aug; 71(1):1-28. PubMed ID: 36006864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influenza Vaccine Effectiveness and Waning Effect in Hospitalized Older Adults. Valencia Region, Spain, 2018/2019 Season.
    Mira-Iglesias A; López-Labrador FX; García-Rubio J; Mengual-Chuliá B; Tortajada-Girbés M; Mollar-Maseres J; Carballido-Fernández M; Schwarz-Chavarri G; Puig-Barberà J; Díez-Domingo J
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33514058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.
    Darvishian M; Dijkstra F; van Doorn E; Bijlsma MJ; Donker GA; de Lange MM; Cadenau LM; Hak E; Meijer A
    PLoS One; 2017; 12(1):e0169528. PubMed ID: 28068386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.
    Kawai N; Ikematsu H; Kawashima T; Maeda T; Ukai H; Hirotsu N; Iwaki N; Kashiwagi S
    Influenza Other Respir Viruses; 2013 May; 7(3):448-55. PubMed ID: 22897904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The 2015-2016 influenza epidemic in Beijing, China: Unlike elsewhere, circulation of influenza A(H3N2) with moderate vaccine effectiveness.
    Zhang L; Pan Y; Hackert V; van der Hoek W; Meijer A; Krafft T; Yang P; Wang Q
    Vaccine; 2018 Aug; 36(33):4993-5001. PubMed ID: 30017144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012-2013 Through 2017-2018.
    Kim SS; Flannery B; Foppa IM; Chung JR; Nowalk MP; Zimmerman RK; Gaglani M; Monto AS; Martin ET; Belongia EA; McLean HQ; Jackson ML; Jackson LA; Patel M
    Clin Infect Dis; 2021 Aug; 73(3):497-505. PubMed ID: 32505128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
    Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
    J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011.
    Savulescu C; Jiménez-Jorge S; Delgado-Sanz C; de Mateo S; Pozo F; Casas I; Larrauri A;
    Vaccine; 2014 Jul; 32(35):4404-4411. PubMed ID: 24968153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project.
    Rondy M; Larrauri A; Casado I; Alfonsi V; Pitigoi D; Launay O; Syrjänen RK; Gefenaite G; Machado A; Vučina VV; Horváth JK; Paradowska-Stankiewicz I; Marbus SD; Gherasim A; Díaz-González JA; Rizzo C; Ivanciuc AE; Galtier F; Ikonen N; Mickiene A; Gomez V; Kurečić Filipović S; Ferenczi A; Korcinska MR; van Gageldonk-Lafeber R; ; Valenciano M
    Euro Surveill; 2017 Jul; 22(30):. PubMed ID: 28797322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.
    Maurel M; Howard J; Kissling E; Pozo F; Pérez-Gimeno G; Buda S; Sève N; McKenna A; Meijer A; Rodrigues AP; Martínez-Baz I; Mlinarić I; Latorre-Margalef N; Túri G; Lazăr M; Mazagatos C; Echeverria A; Abela S; Bourgeois M; Machado A; Dürrwald R; Petrović G; Oroszi B; Jancoriene L; Marin A; Husa P; Duffy R; Dijkstra F; Gallardo García V; Goerlitz L; Enouf V; Bennett C; Hooiveld M; Guiomar R; Trobajo-Sanmartín C; Višekruna Vučina V; Samuelsson Hagey T; Lameiras Azevedo AS; Castilla J; Xuereb G; Delaere B; Gómez V; Tolksdorf K; Bacci S; Nicolay N; Kaczmarek M; Rose AM;
    Euro Surveill; 2024 Feb; 29(8):. PubMed ID: 38390651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China.
    Yang P; Thompson MG; Ma C; Shi W; Wu S; Zhang D; Wang Q
    Vaccine; 2014 Sep; 32(41):5285-9. PubMed ID: 25092635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated.
    Ohmit SE; Petrie JG; Malosh RE; Johnson E; Truscon R; Aaron B; Martens C; Cheng C; Fry AM; Monto AS
    J Infect Dis; 2016 Apr; 213(8):1229-36. PubMed ID: 26597255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 2012-2013 Seasonal influenza vaccine effectiveness against influenza hospitalizations: results from the global influenza hospital surveillance network.
    Puig-Barberà J; Natividad-Sancho A; Launay O; Burtseva E; Ciblak MA; Tormos A; Buigues-Vila A; Martínez-Úbeda S; Sominina A;
    PLoS One; 2014; 9(6):e100497. PubMed ID: 24945510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influenza vaccine effectiveness against laboratory-confirmed influenza in a vaccine-mismatched influenza B-dominant season.
    Drori Y; Pando R; Sefty H; Rosenberg A; Mendelson E; Keinan-Boker L; Shohat T; Mandelboim M; Glatman-Freedman A;
    Vaccine; 2020 Dec; 38(52):8387-8395. PubMed ID: 33243633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influenza Vaccine Effectiveness in the United States During the 2016-2017 Season.
    Flannery B; Chung JR; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Rolfes MA; Spencer S; Fry AM;
    Clin Infect Dis; 2019 May; 68(11):1798-1806. PubMed ID: 30204854
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014.
    Sullivan SG; Carville KS; Chilver M; Fielding JE; Grant KA; Kelly H; Levy A; Stocks NP; Tempone SS; Regan AK
    Epidemiol Infect; 2016 Aug; 144(11):2317-28. PubMed ID: 27125368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.
    Gaglani M; Pruszynski J; Murthy K; Clipper L; Robertson A; Reis M; Chung JR; Piedra PA; Avadhanula V; Nowalk MP; Zimmerman RK; Jackson ML; Jackson LA; Petrie JG; Ohmit SE; Monto AS; McLean HQ; Belongia EA; Fry AM; Flannery B
    J Infect Dis; 2016 May; 213(10):1546-56. PubMed ID: 26743842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro neuraminidase inhibitory concentration (IC
    Ikematsu H; Kawai N; Tani N; Chong Y; Bando T; Iwaki N; Kashiwagi S
    J Infect Chemother; 2020 Aug; 26(8):775-779. PubMed ID: 32249161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019.
    Doyle JD; Chung JR; Kim SS; Gaglani M; Raiyani C; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Foust A; Sessions W; Berman L; Garten RJ; Barnes JR; Wentworth DE; Fry AM; Patel MM; Flannery B
    MMWR Morb Mortal Wkly Rep; 2019 Feb; 68(6):135-139. PubMed ID: 30763298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
    Rose AMC; Pozo F; Martínez-Baz I; Mazagatos C; Bossuyt N; Cauchi JP; Petrović G; Loghin II; Vaikutyte R; Buda S; Machado A; Duffy R; Oroszi B; Howard J; Echeverria A; Andreu C; Barbezange C; Džiugytė A; Nonković D; Popescu CP; Majauskaite F; Tolksdorf K; Gomez V; Domegan L; Horváth JK; Castilla J; García M; Demuyser T; Borg ML; Tabain I; Lazar M; Kubiliute I; Dürrwald R; Guiomar R; O'Donnell J; Kristóf K; Nicolay N; Bacci S; Kissling E; ;
    Influenza Other Respir Viruses; 2024 Feb; 18(2):e13255. PubMed ID: 38403302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.